Alan J Budney, PhD
Title(s)
Professor of Psychiatry
Professor of Biomedical Data Science
Additional Titles/Positions/Affiliations
Director, T32 Predoctoral and Postdoctoral Training Program in the Science of Co-occurring Disorders
Director, Treatment Development and Evaluation Core, Center for Technology and Behavioral Health (P30 Center of Excellence - Marsch, PI)
Department(s)
Psychiatry
Biomedical Data Science
Education
Postdoctoral Fellowship, Substance Abuse and Behavioral Pharmacology, University of Vermont (1990-93)
Ph.D., Clinical Psychology, Rutgers University (1989)
B.S., Psychology with Honors, Pennsylvania State University (1981)
Websites
http:
https:
Contact Information
Geisel School of Medicine at Dartmouth
Center for Technology and Behavioral Health
46 Centerra Pkwy, Suite 315, HB 7255
Lebanon, NH 03766
Office: 603-646-7088
Phone: 501-626-6568
Email: Alan.J.Budney@Dartmouth.edu
Professional Interests
Prevention and Intervention; Treatment Development; Marijuana / Cannabis Pharmacology, Phenomenology, Regulatory Science; Substance Use Etiology.
Grant Information
T32DA037202-07 Budney (PI) 07/01/2019 - 6/30/2024
NIH/NIDA: Science of Co-Occurring Disorders
This training award supports the training of 4 postdoctoral and 3 pre-doctoral trainees. Training focuses on the development of researchers interested in the co-occurrence of substance use disorders and other types of related mental or physical health conditions. Areas of research range from neuroscience to health services.
R01DA050032-01 Budney (PI) 09/30/2020-07/31/2025
NIH/NIDA: Leveraging Social Media to Develop the Cannabis Exposure Index (CEI), A
Standardized Measure of Cannabis Use
This project will develop and validate a measure of cannabis consumption that will enhance the capacities of clinical, epidemiologic and policy studies and lead to more informed communication about cannabis and its risks to clinicians, health educators and policy makers.
P30DA029926-10 Marsch (PI) 07/01/2011 – 05/31/2021
NIH/NIDA: Technology-based Treatments for Substance Use Disorders
This P30 “Center of Excellence” grant supports a research center focused on research and development activities that systematically combine science-based behavior change interventions with state-of-the-science technologies to create, evaluate, and disseminate digital therapeutics targeting substance use disorders and related issues (including HIV risk behavior and mental health conditions).
Role: Director, Treatment and Development Core
R01DA027232 Al'absi (PI) 09/01/2017-06/30/2021
NIH/NIDA: Effect of sex differences and concurrent cannabis use on stress-related psychobiological mechanisms associated with smoking cessation and relapse
This project will use novel stress-related measures and focus on sex differences in effects of concurrent cannabis use in smokers interested in tobacco cessation. Role: Co-I
R01 DA044670 Barrington; Leventhal (MPI) 09/20/2019-08/31/2024
NCI: Vaping Nicotine and Cannabis Across Adolescence and Young Adulthood.
This study will provide new essential information about whether low-risk AYAs begin nicotine and cannabis use via vaping, and whether vaping may lead to adverse consequences, including cigarette and cannabis smoking. Role: Co-I
1UG1DA040309-06 Marsch ( PI) 07/1/2015 - 02/28/2025
NIH/NIDA
Northeast Node of the National Drug Abuse Clinical Trials Network
The Northeast Node reflects a research partnership in which NIDA, researchers, and community-based providers develop, evaluate, and disseminate new prevention and treatment options for substance use disorders in community-based medical settings in Maine, New Hampshire, and Vermont. Role: Co-I
K23DA042130 Montgomery (PI) 08/15/2017-07/31/2022
NIH/NIDA: Twitter-Based Intervention for Young Adult African American Blunt Smokers.
This project involves the development and evaluation of a low-cost, fully automated and accessible internet-based social media (i.e., Twitter) treatment intervention to help reduce blunt use among young African American adults. Role: Co-Mentor
K01DA046697 Meacham 04/01/2019-03/31/2024
NIH/NIDA: Using Digital Tools to Understand Contexts and Consequences of High-THC Cannabis Use.
This project will provide much needed information on emerging cannabis products and methods of use, perceived and experienced health risks, and existing digital health resources. Role: Co-Mentor
5K01DA047912 Okafor 08/01/2019-07/31/2024
NIH/NIDA: The impact of cannabinoids on inflammation, HIV viral load and symptoms of distress among persons living with HIV.
Findings from this study will provide timely data on the impact of THC and CBD on symptoms of distress, inflammation and HIV viral load in persons living with HIV. Role: Co-Mentor
Mentoring Information
Current Postdoctoral Fellow: Cara Struble, Ph.D (Wayne State)
Current Graduate Student:
Profiles of Depressive Symptoms Among Pregnant Patients Carrying Fetuses with Congenital Anomalies. Developing an online cannabis store paradigm for Cannabis Regulatory Science. Self-titration of cannabis consumption: An epidemiological perspective. Estimating Cannabis Consumption in Milligrams of THC From Self-Reported Hit Size. Impact of nicotine, cannabis, co-use and non-use on single day morning and evening cortisol and subjective state: During ambulatory assessment. Determining associations between prenatal maternal mental health and social determinants of health with outcomes in children with critical CHD. Age Differences in Cannabis Consumption Patterns and in Associations Between Delta-9-Tetrahydrocannabinol Intake and Cannabis Use Disorders Among Adults with Daily Use. Quantity of delta-9-tetrahydrocannabinol consumption and cannabis use disorder among daily cannabis consumers. Patient-provider interactions about cannabis for therapeutic purposes vary as a function of provider type: A pilot study. Momentary mindfulness versus distraction coping messages to reduce cannabis craving among young adults: A microrandomized trial. |
|